Activated protein C resistance, factor V Leiden and assessment of thrombotic risk

Ir Med J. 2008 Sep;101(8):256-7.

Abstract

Venous thromboembolism comprises deep vein thrombosis (DVT) and pulmonary embolism (PE). Acute venous thromboembolism (VTE) is a serious and potentially fatal disorder which often complicates the course of hospitalized patients, but also affects ambulatory and otherwise healthy people. The annual incidence of venous thromboembolism is 1 to 2 cases per 1000 person and the risk of the disorder rises exponentially with age, from an annual rate of less than 5 per 100,000 children to greater than 400 per 100,000 adults older than 80 years.

Publication types

  • Case Reports

MeSH terms

  • Activated Protein C Resistance / diagnosis
  • Activated Protein C Resistance / drug therapy
  • Activated Protein C Resistance / physiopathology*
  • Adult
  • Anticoagulants / therapeutic use
  • Factor V*
  • Humans
  • Male
  • Pulmonary Embolism / etiology*
  • Risk Assessment
  • Risk Factors
  • Venous Thromboembolism / diagnosis
  • Venous Thromboembolism / drug therapy
  • Venous Thromboembolism / etiology*
  • Venous Thrombosis / diagnosis
  • Venous Thrombosis / drug therapy
  • Venous Thrombosis / etiology*
  • Young Adult

Substances

  • Anticoagulants
  • factor V Leiden
  • Factor V